Track the 富士製薬工業株式会社 share price and the full insider trade history of the company, a publicly traded company based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 富士製薬工業株式会社 has logged 11 reports. Market capitalisation: €49.5bn. The latest transaction was reported on 24 June 2026 (Holding update). Among the most active insiders: Nomura Securities Co.,Ltd.. All data is free.
Analysts rate 富士製薬工業株式会社 Buy (bullish), based on 2 analysts. Average price target: JP¥2,850.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Fuji Pharma Co., Ltd. is a Japanese company operating in the healthcare and pharmaceutical sector. It focuses on the research, development, and marketing of pharmaceutical products.